99% Purity Antimicrobial Ozenoxacin Pharmaceutical Ozenoxacin Powder Ozenoxacin

China 99% Purity Antimicrobial Ozenoxacin Pharmaceutical Ozenoxacin Powder Ozenoxacin, Find details about China Ozenoxacin, Ozenoxacin Intermediate from 99% Purity Antimicrobial Ozenoxacin Pharmaceutical Ozenoxacin Powder Ozenoxacin

Model NO.
D-sung Ozenoxacin
Product Name
Ozenoxacin
Name
Ozenoxacin Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical; Antimicrobial
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
245765-41-7
Mf
C21h21n3o3
MW
363.417
Density
1.372±0.06 g/cm3
Boiling Point
573.5±50.0 °c
Trademark
D-sung
Transport Package
Negotiable
Specification
99%
Origin
Shaanxi Xi′an
Model NO.
D-sung Ozenoxacin
Product Name
Ozenoxacin
Name
Ozenoxacin Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical; Antimicrobial
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
245765-41-7
Mf
C21h21n3o3
MW
363.417
Density
1.372±0.06 g/cm3
Boiling Point
573.5±50.0 °c
Trademark
D-sung
Transport Package
Negotiable
Specification
99%
Origin
Shaanxi Xi′an

99% Purity Antimicrobial Ozenoxacin Pharmaceutical Ozenoxacin Powder Ozenoxacin
99% Purity Antimicrobial Ozenoxacin Pharmaceutical Ozenoxacin Powder Ozenoxacin
Product Description
99% Purity Antimicrobial Ozenoxacin Pharmaceutical Ozenoxacin Powder Ozenoxacin99% Purity Antimicrobial Ozenoxacin Pharmaceutical Ozenoxacin Powder Ozenoxacin
Product Details
99% Purity Antimicrobial Ozenoxacin Pharmaceutical Ozenoxacin Powder Ozenoxacin
Product nameOzenoxacin
Cas number245765-41-7
AppearanceWhite powder
MFC21H21N3O3
MW363.417
Ozefloxacin is a quinolone antibacterial drug developed by Ferrer Internacional Co., Ltd. of Spain. It was purchased by Medimetriks Pharmaceuticals of the United States and obtained the exclusive commercialization rights in the United States.

In September 2015, it was approved by the Ministry of Health, Labour and Welfare of Japan, becoming the world's first approved new molecular entity. , Which was approved by the U.S. FDA for listing on December 11, 2017.
Application&Function
99% Purity Antimicrobial Ozenoxacin Pharmaceutical Ozenoxacin Powder Ozenoxacin
Application of Ozefloxacin Powder :
Ozefloxacin is used to treat impetigo caused by Staphylococcus aureus or Streptococcus pyogenes in patients aged two months and over. In clinical trials, Ozefloxacin was used to treat skin and soft tissue infections, and the efficacy was better than mupirocin, with no obvious adverse reactions.

Ozefloxacin has significantly stronger inhibitory effects on MRSA, methicillin-sensitive Staphylococcus aureus (MSSA), and ofloxacin-resistant Staphylococcus aureus than nafloxacin, ofloxacin, levofloxacin, clindamycin, etc. , Erythromycin and gentamicin. Ozefloxacin has strong bactericidal activity and can become a new quinolone drug that shortens the course of treatment and has good clinical application prospects.


Function of Ozefloxacin Powder :
Ozenoxacin is a quinolone drug used to treat impetigo. Ozefloxacin's mechanism of action is to inhibit bacterial DNA replicase, DNA gyrase A and topoisomerase IV. Ozefloxacin is the third non-fluoroquinolone antibacterial drug approved in the world after nanofloxacin and garefloxacin.
Specification
99% Purity Antimicrobial Ozenoxacin Pharmaceutical Ozenoxacin Powder Ozenoxacin99% Purity Antimicrobial Ozenoxacin Pharmaceutical Ozenoxacin Powder Ozenoxacin99% Purity Antimicrobial Ozenoxacin Pharmaceutical Ozenoxacin Powder Ozenoxacin
99% Purity Antimicrobial Ozenoxacin Pharmaceutical Ozenoxacin Powder Ozenoxacin99% Purity Antimicrobial Ozenoxacin Pharmaceutical Ozenoxacin Powder Ozenoxacin99% Purity Antimicrobial Ozenoxacin Pharmaceutical Ozenoxacin Powder Ozenoxacin
99% Purity Antimicrobial Ozenoxacin Pharmaceutical Ozenoxacin Powder Ozenoxacin